Skip to main content
Clinical Trials/NCT02768142
NCT02768142
Completed
Not Applicable

The Impact of "Natural" Cesarean Delivery on Peripartum Maternal Blood Loss. A Randomized Controlled Trial.

Raed Salim1 site in 1 country214 target enrollmentStarted: August 2016Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Raed Salim
Enrollment
214
Locations
1
Primary Endpoint
Hemoglobin level after delivery

Overview

Brief Summary

Throughout the history, the neonate was dependent on maternal touch and care for survival. In modern obstetrics, with hospital care the neonates are seldom separated from their mothers after delivery. Early skin to skin (ESTS) contact after delivery was found to increase milk production, lactation and improve maternal and neonatal outcome.

Oxytocin is the primary hormone responsible for uterine contraction and prevention of postpartum hemorrhage (PPH). ESTS contact increases oxytocin secretion.

The rate of cesarean deliveries (CDs) increased dramatically over the past decades. CD was found to decrease postpartum milk production, postpones early lactation and decreases exclusive breastfeeding.

During the typical CD, the neonate is usually presented for a short while to the mother and breastfeeding is usually delayed at least a number of hours until after the surgery and the recovery period.

Natural CD, enable ESTS contact during the surgery and give the mother the opportunity to start breastfeeding immediately after delivery of the neonate in the surgery suit. Oxytocin secretion increases with ESTS and during breastfeeding.

The aim of this study is to examine blood loss that occurs after Natural CD compared to standard CD without an ESTS contact.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
8 Years to 45 Years (Child, Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Estimated to be appropriate for gestational age fetus.
  • Sonographic dating before 20 weeks of gestation.

Exclusion Criteria

  • Non-scheduled CD.
  • Major fetal malformations.
  • Multiple gestations.
  • Non-controlled diabetes.
  • Severe pre-eclampsia.
  • General anesthesia.
  • HIV carrier
  • Neonatal need for early resuscitation.

Outcomes

Primary Outcomes

Hemoglobin level after delivery

Time Frame: 4 days

Difference between pre- and post-surgical hemoglobin levels.

Secondary Outcomes

  • Pain score during the operation(1 hour)
  • Neonatal temperature after delivery(1 hour)
  • Breast engorgement(4 days)
  • Analgesia use during the operation(1 hour)
  • Blood product transfusion(4 days)
  • Pain score during the first day after cesarean delivery(24 hours)
  • Rate of breastfeeding at maternal hospital discharge(4 days)
  • Rate of breastfeeding 6 months after delivery(6 months)
  • Maternal satisfaction of the delivery(4 days)
  • Analgesia use during the first day after cesarean delivery(24 hours)

Investigators

Sponsor
Raed Salim
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Raed Salim

Head of delivery unit

HaEmek Medical Center, Israel

Study Sites (1)

Loading locations...

Similar Trials